Timing of surgery in Crohn's disease: A key issue in the management

World Journal of Gastroenterology

Volumn 14, Issue 36, 2008, Pages 5532-5539

  Alós, Rafael ^a   Hinojosa, Joaquín ^a  

^a HOSPITAL DE SAGUNTO   (Spain)

Author keywords

Crohn's disease; Medical therapy; Surgical treatment

Indexed keywords

ADALIMUMAB; AMINOSALICYLIC ACID; ANTIBIOTIC AGENT; AZATHIOPRINE; INFLIXIMAB; MERCAPTOPURINE; PLACEBO; STEROID; TUMOR NECROSIS FACTOR ANTIBODY;

ABDOMINAL ABSCESS; ANUS FISTULA; ARTICLE; BIOLOGICAL THERAPY; COLON FISTULA; CROHN DISEASE; ENTEROCOLITIS; HUMAN; INTESTINAL BLEEDING; INTESTINE OBSTRUCTION; INTESTINE PERFORATION; PATIENT DECISION MAKING; POSTOPERATIVE COMPLICATION; PROCTOCOLECTOMY; QUALITY OF LIFE; RISK BENEFIT ANALYSIS; SURGICAL APPROACH; SURGICAL RISK; TOXIC MEGACOLON; TREATMENT FAILURE; TREATMENT PLANNING; COLON RESECTION; PATIENT CARE; PATIENT PARTICIPATION; PATIENT SATISFACTION; PATIENT SELECTION; REVIEW; TIME;

COLECTOMY; CROHN DISEASE; HUMANS; PATIENT CARE TEAM; PATIENT PARTICIPATION; PATIENT SATISFACTION; PATIENT SELECTION; QUALITY OF LIFE; TIME FACTORS; TREATMENT FAILURE;

EID: 58149184697     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.14.5532     Document Type: Article

References (66)

1. Truelove SC, Witts LJ. Cortisone in ulcerative colitis; preliminary report on a therapeutic trial. Br Med J 1954; 2: 375-378
2. Rutgeerts PJ. An historical overview of the treatment of Crohn's disease: why do we need biological therapies? Rev Gastroenterol Disord 2004; 4 Suppl 3: S3-S9
3. van Dullemen HM, van Deventer SJ, Hommes DW, Bijl HA, Jansen J, Tytgat GN, Woody J. Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology 1995; 109: 129-135
4. Bernell O, Lapidus A, Hellers G. Risk factors for surgery and recurrence in 907 patients with primary ileocaecal Crohn's disease. Br J Surg 2000; 87: 1697-1701
5. Nicholls J. The inflammatory bowel disease unit and the multidisciplinary team meeting. Colorectal Dis 2007; 9: 477
6. Lichtenstein GR, Yan S, Bala M, Blank M, Sands BE. Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulizing Crohn's disease. Gastroenterology 2005; 128: 862-869
7. Colombel JF, Loftus EV Jr, Tremaine WJ, Pemberton JH, Wolff BG, Young-Fadok T, Harmsen WS, Schleck CD, Sandborn WJ. Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy. Am J Gastroenterol 2004; 99: 878-883
8. Marchal L, D'Haens G, Van Assche G, Vermeire S, Noman M, Ferrante M, Hiele M, Bueno De Mesquita M, D'Hoore A, Penninckx F, Rutgeerts P. The risk of post-operative complications associated with infliximab therapy for Crohn's disease: a controlled cohort study. Aliment Pharmacol Ther 2004; 19: 749-754
9. Shen B. Impact of preoperative infliximab use on postoperative infectious complications in ulcerative colitis: the price we have to pay? Inflamm Bowel Dis 2008; 14: 1019-1021
10. Selvasekar CR, Cima RR, Larson DW, Dozois EJ, Harrington JR, Harmsen WS, Loftus EV Jr, Sandborn WJ, Wolff BG, Pemberton JH. Effect of infliximab on short-term complications in patients undergoing operation for chronic ulcerative colitis. J Am Coll Surg 2007; 204: 956-962; discussion 962-963
11. Peyrin-Biroulet L, Deltenre P, de Suray N, Branche J, Sandborn WJ, Colombel JF. Efficacy and safety of tumor necrosis factor antagonists in Crohn's disease: meta-analysis of placebo-controlled trials. Clin Gastroenterol Hepatol 2008; 6: 644-653
12. Farmer RG, Whelan G, Fazio VW. Long-term follow-up of patients with Crohn's disease. Relationship between the clinical pattern and prognosis. Gastroenterology 1985; 88: 1818-1825
13. Michelassi F, Balestracci T, Chappell R, Block GE. Primary and recurrent Crohn's disease. Experience with 1379 patients. Ann Surg 1991; 214: 230-238; discussion 238-240
14. Hanauer SB, Meyers S. Management of Crohn's disease in adults. Am J Gastroenterol 1997; 92: 559-566
15. Lopez-San Roman A, Obrador A, Fortun J, Munoz P, Gassull MA. [Recommendations on tuberculosis and treatment of inflammatory bowel disease with infliximab. 2006 update] Gastroenterol Hepatol 2006; 29: 81-84
16. Faubion WA Jr, Loftus EV Jr, Harmsen WS, Zinsmeister AR, Sandborn WJ. The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. Gastroenterology 2001; 121: 255-260
17. Tung J, Loftus EV Jr, Freese DK, El-Youssef M, Zinsmeister AR, Melton LJ 3rd, Harmsen WS, Sandborn WJ, Faubion WA Jr. A population-based study of the frequency of corticosteroid resistance and dependence in pediatric patients with Crohn's disease and ulcerative colitis. Inflamm Bowel Dis 2006; 12: 1093-1100
18. Nordgren SR, Fasth SB, Oresland TO, Hulten LA. Long-term follow-up in Crohn's disease. Mortality, morbidity, and functional status. Scand J Gastroenterol 1994; 29: 1122-1128
19. Edna TH, Bjerkeset T, Skreden K. Abdominal surgery for Crohn's disease during 30 years in Middle Norway. Hepatogastroenterology 2004; 51: 481-484
20. Sands BE, Arsenault JE, Rosen MJ, Alsahli M, Bailen L, Banks P, Bensen S, Bousvaros A, Cave D, Cooley JS, Cooper HL, Edwards ST, Farrell RJ, Griffin MJ, Hay DW, John A, Lidofsky S, Olans LB, Peppercorn MA, Rothstein RI, Roy MA, Saletta MJ, Shah SA, Warner AS, Wolf JL, Vecchio J, Winter HS, Zawacki JK. Risk of early surgery for Crohn's disease: implications for early treatment strategies. Am J Gastroenterol 2003; 98: 2712-2718
21. Morimoto N, Kato J, Kuriyama M, Fujimoto T, Nasu J, Miyaike J, Morita T, Okada H, Suzuki S, Shiode J, Yamamoto H, Sakaguchi K, Shiratori Y. Risk factors and indications for first surgery in Crohn's disease patients. Hepatogastroenterology 2007; 54: 2011-2016
22. Yamamoto T, Allan RN, Keighley MR. Risk factors for intra-abdominal sepsis after surgery in Crohn's disease. Dis Colon Rectum 2000; 43: 1141-1145
23. Alves A, Panis Y, Bouhnik Y, Pocard M, Vicaut E, Valleur P. Risk factors for intra-abdominal septic complications after a first ileocecal resection for Crohn's disease: a multivariate analysis in 161 consecutive patients. Dis Colon Rectum 2007; 50: 331-336
24. Scott NA, Hughes LE. Timing of ileocolonic resection for symptomatic Crohn's disease - the patient's view. Gut 1994; 35: 656-657
25. Higuero T, Merle C, Thiefin G, Coussinet S, Jolly D, Diebold MD, Zeitoun P, Cadiot G. Jejunoileal Crohn's disease: a case-control study. Gastroenterol Clin Biol 2004; 28: 160-166
26. Lledo S. Crohn's Disease. Clinical Guides of the Spanish Association of Surgeons. 1th ed. Madrid: Aran Editions SA, 2000: 205-230
27. Ferlitsch A, Reinisch W, Puspok A, Dejaco C, Schillinger M, Schofl R, Potzi R, Gangl A, Vogelsang H. Safety and efficacy of endoscopic balloon dilation for treatment of Crohn's disease strictures. Endoscopy 2006; 38: 483-487
28. Ajlouni Y, Iser JH, Gibson PR. Endoscopic balloon dilatation of intestinal strictures in Crohn's disease: safe alternative to surgery. J Gastroenterol Hepatol 2007; 22: 486-490
29. Garcia JC, Persky SE, Bonis PA, Topazian M. Abscesses in Crohn's disease: outcome of medical versus surgical treatment. J Clin Gastroenterol 2001; 32: 409-412
30. Gervais DA, Hahn PF, O'Neill MJ, Mueller PR. Percutaneous abscess drainage in Crohn disease: technical success and short- and long-term outcomes during 14 years. Radiology 2002; 222: 645-651
31. Lee H, Kim YH, Kim JH, Chang DK, Son HJ, Rhee PL, Kim JJ, Paik SW, Rhee JC. Nonsurgical treatment of abdominal or pelvic abscess in consecutive patients with Crohn's disease. Dig Liver Dis 2006; 38: 659-664
32. Neufeld D, Keidar A, Gutman M, Zissin R. Abdominal wall abscesses in patients with Crohn's disease: clinical outcome. J Gastrointest Surg 2006; 10: 445-449
33. Hill GL, Bourchier RG, Witney GB. Surgical and metabolic management of patients with external fistulas of the small intestine associated with Crohn's disease. World J Surg 1988; 12: 191-197
34. Poritz LS, Gagliano GA, McLeod RS, MacRae H, Cohen Z. Surgical management of entero and colocutaneous fistulae in Crohn's disease: 17 year's experience. Int J Colorectal Dis 2004; 19: 481-485; discussion 486
35. Present DH, Rutgeerts P, Targan S, Hanauer SB, Mayer L, van Hogezand RA, Podolsky DK, Sands BE, Braakman T, DeWoody KL, Schaible TF, van Deventer SJ. Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med 1999; 340: 1398-1405
36. McNamara MJ, Fazio VW, Lavery IC, Weakley FL, Farmer RG. Surgical treatment of enterovesical fistulas in Crohn's disease. Dis Colon Rectum 1990; 33: 271-276
37. Khanna MP, Gordon PH. Gastrocolic fistulization in Crohn's disease: a case report and a review of the literature. Can J Surg 2000; 43: 53-56
38. Solem CA, Loftus EV Jr, Tremaine WJ, Pemberton JH, Wolff BG, Sandborn WJ. Fistulas to the urinary system in Crohn's disease: clinical features and outcomes. Am J Gastroenterol 2002; 97: 2300-2305
39. Hurst RD, Molinari M, Chung TP, Rubin M, Michelassi F. Prospective study of the features, indications, and surgical treatment in 513 consecutive patients affected by Crohn's disease. Surgery 1997; 122: 661-667; discussion 667-668
40. Mowatt JI, Burnstein MJ. Free perforation of small bowel Crohn's disease: A case report and review. Can J Gastroenterol 1993; 7: 300-302
41. Cirocco WC, Reilly JC, Rusin LC. Life-threatening hemorrhage and exsanguination from Crohn's disease. Report of four cases. Dis Colon Rectum 1995; 38: 85-95
42. Kostka R, Lukas M. Massive, life-threatening bleeding in Crohn's disease. Chir Belg 2005; 105: 168-174
43. Veroux M, Angriman I, Ruffolo C, Barollo M, Buffone A, Madia C, Caglia P, Fiamingo P, D'Amico D. Severe gastrointestinal bleeding in Crohn's disease. Ann Ital Chir 2003; 74: 213-215; discussion 216
44. Remzi FH, Dietz DW, Unal E, Levitin A, Sands MJ, Fazio VW. Combined use of preoperative provocative angiography and highly selective methylene blue injection to localize an occult small-bowel bleeding site in a patient with Crohn's disease: report of a case. Dis Colon Rectum 2003; 46: 260-263
45. Travis SP, Stange EF, Lemann M, Oresland T, Chowers Y, Forbes A, D'Haens G, Kitis G, Cortot A, Prantera C, Marteau P, Colombel JF, Gionchetti P, Bouhnik Y, Tiret E, Kroesen J, Starlinger M, Mortensen NJ. European evidence based consensus on the diagnosis and management of Crohn's disease: current management. Gut 2006; 55 Suppl 1: i16-i35
46. Fazio VW, Wu JS. Surgical therapy for Crohn's disease of the colon and rectum. Surg Clin North Am 1997; 77: 197-210
47. Travis SP, Farrant JM, Ricketts C, Nolan DJ, Mortensen NM, Kettlewell MG, Jewell DP. Predicting outcome in severe ulcerative colitis. Gut 1996; 38: 905-910
48. Lindgren SC, Flood LM, Kilander AF, Lofberg R, Persson TB, Sjodahl RI. Early predictors of glucocorticosteroid treatment failure in severe and moderately severe attacks of ulcerative colitis. Eur J Gastroenterol Hepatol 1998; 10: 831-835
49. Berg DF, Bahadursingh AM, Kaminski DL, Longo WE. Acute surgical emergencies in inflammatory bowel disease. Am J Surg 2002; 184: 45-51
50. Sheth SG, LaMont JT. Toxic megacolon. Lancet 1998; 351: 509-513
51. Sandborn WJ, Fazio VW, Feagan BG, Hanauer SB. AGA technical review on perianal Crohn's disease. Gastroenterology 2003; 125: 1508-1530
52. Caprilli R, Gassull MA, Escher JC, Moser G, Munkholm P, Forbes A, Hommes DW, Lochs H, Angelucci E, Cocco A, Vucelic B, Hildebrand H, Kolacek S, Riis L, Lukas M, de Franchis R, Hamilton M, Jantschek G, Michetti P, O'Morain C, Anwar MM, Freitas JL, Mouzas IA, Baert F, Mitchell R, Hawkey CJ. European evidence based consensus on the diagnosis and management of Crohn's disease: special situations. Gut 2006; 55 Suppl 1: i36-i58
53. Regueiro M, Mardini H. Treatment of perianal fistulizing Crohn's disease with infliximab alone or as an adjunct to exam under anesthesia with seton placement. Inflamm Bowel Dis 2003; 9: 98-103
54. Regimbeau JM, Panis Y, Marteau P, Benoist S, Valleur P. Surgical treatment of anoperineal Crohn's disease: can abdominoperineal resection be predicted? J Am Coll Surg 1999; 189: 171-176
55. Canavan C, Abrams KR, Mayberry J. Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn's disease. Aliment Pharmacol Ther 2006; 23: 1097-1104
56. Zisman TL, Rubin DT. Colorectal cancer and dysplasia in inflammatory bowel disease. World J Gastroenterol 2008; 14: 2662-2669
57. Eaden JA, Ward BA, Mayberry JF. How gastroenterologists screen for colonic cancer in ulcerative colitis: an analysis of performance. Gastrointest Endosc 2000; 51: 123-128
58. Ekbom A, Helmick C, Zack M, Adami HO. Increased risk of large-bowel cancer in Crohn's disease with colonic involvement. Lancet 1990; 336: 357-359
59. Shamir R, Phillip M, Levine A. Growth retardation in pediatric Crohn's disease: pathogenesis and interventions. Inflamm Bowel Dis 2007; 13: 620-628
60. Waters BM, Jensen L, Fedorak RN. Effects of formal education for patients with inflammatory bowel disease: a randomized controlled trial. Can J Gastroenterol 2005; 19: 235-244
61. Fontanet G, Casellas F, Malagelada JR. [The Crohn-Colitis care unit: analysis of the first 3 years of activity] Gac Sanit 2004; 18: 483-485
62. Mawdsley JE, Irving PM, Makins RJ, Rampton DS. Optimizing quality of outpatient care for patients with inflammatory bowel disease: the importance of specialist clinics. Eur J Gastroenterol Hepatol 2006; 18: 249-253
63. Casellas F, Lopez-Vivancos J, Badia X, Vilaseca J, Malagelada JR. Influence of inflammatory bowel disease on different dimensions of quality of life. Eur J Gastroenterol Hepatol 2001; 13: 567-572
64. Tan WC, Allan RN. Diffuse jejunoileitis of Crohn's disease. Gut 1993; 34: 1374-1378
65. Norman K, Kirchner H, Lochs H, Pirlich M. Malnutrition affects quality of life in gastroenterology patients. World J Gastroenterol 2006; 12: 3380-3385
66. Mitchell A, Guyatt G, Singer J, Irvine EJ, Goodacre R, Tompkins C, Williams N, Wagner F. Quality of life in patients with inflammatory bowel disease. J Clin Gastroenterol 1988; 10: 306-310